Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2023PI008 | Registry Identifier | DRCI |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Retrospective monocentric study of the outcomes of patients with neurogenic bladder, who had a urinary artificial sphincter before the age of 18 years old.
Hypothesis: what was the impact of the urinary artificial sphincter on the global management of the patient.
The management of patients with neurogenic bladder is complex. Several patients have been operated multiple times. Surgical procedures such as Mitrofanoff's, bladder neck surgery, bladder augmentation and urinary artificial sphincter, are common.
The investigators want to analyse the participants data, that led to indication of an urinary artificial sphincter, and its outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Urinary Artificial Sphincter (UAS) in Children | Other | Patients aged under 18 years old with UAS |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with refractory urinary incontinence | Participants with urinary incontinence without response to medical treatment or catheterization | Before surgery |
| Impact of urinary artificial sphincter on the participants' incontinence | Three outcomes are possible: the participant is continent, the participant is continent with catheterization or the patient is incontinent. | Through study completion, an average of 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Impact of bladder augmentation on participants' incontinence | Analysing the presence of bladder augmentation in participants with urinary artificial sphincter. Three outcomes are possible: the participant is continent, the participant is continent with catheterization or the patient is incontinent. | Through study completion, an average of 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients younger than 18 years old who have neurogenic bladders.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christelle Destinval, MD | University of Lorraine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| ULorraine | Vandœuvre-lès-Nancy | Grand Est | 54500 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35340070 | Background | Delgado-Miguel C, Munoz-Serrano A, Amesty V, Rivas S, Lobato R, Martinez-Urrutia MJ, Lopez-Pereira P. Artificial urinary sphincter in congenital neuropathic bladder: Very long-term outcomes. Int J Urol. 2022 Jul;29(7):692-697. doi: 10.1111/iju.14874. Epub 2022 Mar 26. | |
| 1855464 | Background | Sheppard KE, Roberts JL, Blum M. Adrenocorticotropin-releasing factor down-regulates glucocorticoid receptor expression in mouse corticotrope tumor cells via an adenylate cyclase-dependent mechanism. Endocrinology. 1991 Aug;129(2):663-70. doi: 10.1210/endo-129-2-663. |
Not provided
Not provided
In the name of anonymization the investigators won't share individual participant data
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001750 | Urinary Bladder, Neurogenic |
| D016135 | Spinal Dysraphism |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D001745 | Urinary Bladder Diseases |
| D014570 | Urologic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D016741 | Urinary Sphincter, Artificial |
| ID | Term |
|---|---|
| D019736 | Prostheses and Implants |
| D004864 | Equipment and Supplies |
| D001187 | Artificial Organs |
| D013523 | Surgical Equipment |
Not provided
Not provided
Not provided
Not provided
Not provided
| Impact of Mitrofanoff procedure on participants' incontinence | Analysing the presence of Mitrofanoff procedure in participants with urinary artificial sphincter. hree outcomes are possible: the participant is continent, the participant is continent with catheterization or the patient is incontinent. | Through study completion, an average of 2 years |
| Impact of bladder neck surgery on participants' incontinence | Analysing the presence of bladder neck surgery in participants with urinary artificial sphincter. hree outcomes are possible: the participant is continent, the participant is continent with catheterization or the patient is incontinent. | Through study completion, an average of 2 years |
| Complications after urinary artificial sphincter | Medical and surgical complications after urinary artificial sphincter | Through study completion, an average of 2 years |
| Operating time | Operating time | Perioperatively |
| Length of stay | Length of stay | From the day of hospitalization to the day of discharge home, up to 20 days |
| Last follow-up | Follow-up represents the time between the surgery and postoperative consultation dates in days, months, or years. Generally, there are a-month-follow-up, a three month-follow-up, a six month-follow-up, and a year-follow-up. The surgeon can see the patient if there is any problem between these consultations. After a year of follow-up, it is up to the surgeon to decide if the patient needs to be seen yearly or not. The last follow-up date is crucial because it indicates how the patient is and if other follow-up dates need to be applied. | Through study completion, an average of 2 years |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009436 | Neural Tube Defects |
| D009421 | Nervous System Malformations |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |